Primary Amyloidosis
What is Primary Amyloidosis?
Primary amyloidosis is a rare disorder where abnormal proteins build up in your tissues and organs. These proteins form clumps called amyloid deposits. Over time, they can damage your heart, kidneys, liver, nerves, and other organs.
The condition happens when plasma cells in your bone marrow produce too many light chain proteins. These light chains, especially lambda light chains, misfold and stick together. Instead of breaking down normally, they collect in organs and interfere with how those organs work.
Primary amyloidosis is different from secondary amyloidosis. Primary amyloidosis occurs on its own, without another underlying disease causing it. It affects about 8 to 12 people per million each year. Most people are diagnosed after age 50.
Symptoms
- Extreme fatigue that does not improve with rest
- Unexplained weight loss of 10 pounds or more
- Swelling in ankles and legs
- Shortness of breath, especially during activity
- Numbness or tingling in hands and feet
- Diarrhea or constipation
- Enlarged tongue that may look ridged on the sides
- Purple patches or easy bruising around the eyes
- Weakness or lightheadedness when standing
- Irregular heartbeat or feeling of fluttering
Some people have no symptoms in the early stages. Symptoms often develop slowly as protein deposits build up over months or years. The signs depend on which organs are affected first.
Concerned about Primary Amyloidosis? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Primary amyloidosis happens when plasma cells in your bone marrow malfunction. These cells normally make antibodies to fight infection. In primary amyloidosis, they produce too many light chain proteins. These abnormal proteins cannot fold properly, so they clump together and deposit in tissues. Doctors do not fully understand why this happens, but it is not caused by diet or lifestyle choices.
Risk factors include being over age 50, being male, and having certain bone marrow disorders. People with a condition called monoclonal gammopathy have a higher risk. African Americans face a slightly higher risk than other groups. Having a family history of amyloidosis may increase risk, but most cases occur in people with no family history.
How it's diagnosed
Diagnosing primary amyloidosis requires several specialized tests. Your doctor will order blood and urine tests to look for abnormal light chain proteins. Blood tests measure lambda and kappa light chains and their ratio. Urine tests check for excess protein being excreted by your kidneys. These tests can suggest amyloidosis but cannot confirm it alone.
A tissue biopsy confirms the diagnosis. Doctors take a small sample of fat from your abdomen or tissue from an affected organ. They stain the sample with special dyes that make amyloid proteins visible under a microscope. Additional tests identify which type of amyloid protein is present. Imaging tests like echocardiograms and MRI scans show which organs are affected. Talk to your doctor about specialized testing for this condition.
Treatment options
- Chemotherapy medications to stop plasma cells from making abnormal proteins
- Stem cell transplant to replace diseased bone marrow with healthy cells
- Medications to manage heart symptoms like diuretics and blood pressure drugs
- Dialysis if kidney function becomes severely impaired
- Low-salt diet to reduce fluid retention and swelling
- Compression stockings to help with leg swelling and blood pressure
- Physical therapy to maintain strength and manage nerve damage
- Regular monitoring with blood tests and imaging to track disease progression
Frequently asked questions
Primary amyloidosis occurs on its own when plasma cells malfunction and produce abnormal proteins. Secondary amyloidosis develops as a complication of chronic inflammatory diseases like rheumatoid arthritis or inflammatory bowel disease. The type of protein that builds up is different in each form. Treatment approaches also differ based on the type.
Primary amyloidosis is a serious condition that requires treatment. Without treatment, the protein deposits can cause organ failure, especially in the heart and kidneys. However, modern treatments can slow or stop protein production in many people. Early diagnosis and treatment improve outcomes significantly.
Primary amyloidosis cannot be fully cured, but it can be managed. Treatment aims to stop the production of abnormal proteins and prevent further organ damage. Some people achieve remission where no abnormal proteins are detected. Existing amyloid deposits may slowly decrease over time with successful treatment.
Blood tests measure free light chains, specifically lambda and kappa proteins. Doctors look at the ratio between these two types of light chains. An abnormal ratio suggests a plasma cell disorder. Additional blood tests check for other markers and assess organ function, especially kidney and liver health.
Progression varies widely between individuals. Some people experience rapid progression over months, while others have a slower course over years. The rate depends on how much abnormal protein is being produced and which organs are affected. Heart involvement typically leads to faster progression than other organ involvement alone.
The heart and kidneys are most commonly affected, occurring in about 70% and 50% of cases respectively. The liver, nervous system, and digestive tract can also be involved. Some people have deposits in multiple organs. The pattern of organ involvement affects symptoms and treatment approach.
Primary amyloidosis is not usually hereditary. Most cases occur sporadically without a family history. There is a rare hereditary form called familial amyloidosis, but this is different from primary amyloidosis. If you have concerns about family risk, discuss genetic counseling with your doctor.
Lifestyle changes cannot stop the disease but can help manage symptoms. A low-salt diet reduces fluid buildup and swelling. Staying physically active within your limits helps maintain strength. Avoiding alcohol protects your liver and heart. Good nutrition supports overall health during treatment.
Life expectancy varies greatly depending on organ involvement and treatment response. Untreated, median survival may be 1 to 2 years. With modern treatments, many people live 5 years or longer. Those who achieve remission can live much longer. Early diagnosis and treatment are key to better outcomes.
Monitoring frequency depends on your disease stage and treatment. During active treatment, you may need blood tests every few weeks to months. Once stable, testing every 3 to 6 months is common. Your doctor will also schedule regular imaging tests and physical exams to check organ function and watch for disease changes.